Inclusion body myopathy (Q41418)
From determinar.ia.br - Determine suas informações
Inclusion body myopathy (IBM) is distinguished from polymyositis (PM) and dermatomyositis (DM) on the basis of clinical and histopathological features. A characteristic clinical phenotype is characterised by insidious onset of muscle weakness over months to years, muscle weakness localised predominantly in the thigh muscles and finger flexors, and resistance to glucocorticoid treatment. Typical histopathologic features include sarcoplasmic and nuclear inclusions and rimmed vacuoles.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A41.2 |
||
| English | Inclusion body myopathy |
Inclusion body myopathy (IBM) is distinguished from polymyositis (PM) and dermatomyositis (DM) on the basis of clinical and histopathological features. A characteristic clinical phenotype is characterised by insidious onset of muscle weakness over months to years, muscle weakness localised predominantly in the thigh muscles and finger flexors, and resistance to glucocorticoid treatment. Typical histopathologic features include sarcoplasmic and nuclear inclusions and rimmed vacuoles. |
Statements
CID11:4A41.2
0 references
dki-india-4A41.2
0 references
Concluído
0 references
13 August 2026
0 references
